Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib effectively promotes hair regrowth in both scalp and nonscalp areas for alopecia areata universalis patients.

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

Poncirin is a promising inhibitor of Janus Kinase 3, potentially better than tofacitinib.

Upadacitinib is effective and safe for treating severe Alopecia Areata in adolescents.

BD 1/4 dilution is the best for treating localized alopecia areata in adults.

The new omeprazole nanoemulgel shows promise as a topical treatment for infections.

Pistacia atlantica leaf ointment effectively heals wounds like phenytoin, with added antibacterial and anti-inflammatory benefits.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

Clotrimazole, miconazole, and tolnaftate are likely safe, but gentian violet is risky.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Janus kinase inhibitors are effective for severe alopecia areata, promoting hair regrowth.

A woman kept her eyelashes during chemotherapy possibly because of her glaucoma eye drops.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

Filgotinib completely reversed hair loss in a patient with rheumatoid arthritis and alopecia universalis.

New hydrogel dressing with antibiotic speeds up burn healing and skin regeneration.

Topical calcitriol may reduce hair loss from chemotherapy at higher doses.

Stopping erlotinib improved severe hair loss and skin issues in a patient.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.

The gel improves hair regrowth and reduces irritation in alopecia areata treatment.

Erosive pustular dermatosis of the scalp can occur about 17 weeks after starting EGFR inhibitors, and early minocycline may help manage it.

JAK inhibitors effectively treat severe atopic dermatitis and alopecia areata.

Combining injections with lotion is more effective for hair regrowth in alopecia areata than using the lotion alone.

Kerion cases had longer disease duration but responded well to antifungal treatments.

Deucravacitinib helped regrow hair and reduce plaques in a woman with discoid lupus erythematosus without side effects.

The combined treatment effectively managed severe skin issues in Olmsted syndrome.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.